AbbVie (NYSE:ABBV) Price Target Lowered to $215.00 at Citigroup

5 days ago · November 12, 2024. AbbVie (NYSE:ABBV - Get Free Report) had its price objective lowered by Citigroup from $226.00 to $215.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. Citigroup's target price would …

CouponFollow Extension

$215.00
OFF

AbbVie (NYSE:ABBV) Price Target Lowered To $215.00 At Citigroup

1 week from now

marketbeat.com

$203.83
OFF

AbbVie (ABBV) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

3 days ago · According to the 20 analysts' twelve-month price targets for AbbVie, the average price target is $203.83. The highest price target for ABBV is $225.00, while the lowest price …

marketbeat.com

$215
OFF

AbbVie Price Target Lowered To $215 From $226 At Citi - Nasdaq

1 week from now

5 days ago · November 12, 2024 — 06:00 am EST. Written by TheFly for TipRanks ->. Citi analyst Geoff Meacham lowered the firm’s price target on AbbVie (ABBV) to $215 from $226 …

nasdaq.com

$215.00
OFF

AbbVie (NYSE:ABBV) Price Target Increased To $215.00 By

1 week from now

Oct 25, 2024 · AbbVie (NYSE:ABBV - Free Report) had its price target raised by Citigroup from $170.00 to $215.00 in a research note published on Friday morning, Benzinga reports. …

marketbeat.com

$221
OFF

ABBV Stock Price | AbbVie Inc. Stock Quote (U.S.: NYSE)

1 week from now

Nov 8, 2024 · AbbVie price target raised to $221 from $212 at Guggenheim Nov. 6, 2024 at 7:37 a.m. ET on TipRanks.com. Truist Financial Sticks to Its Buy Rating for AbbVie (ABBV) Nov. 6, …

marketwatch.com

$203.83
OFF

ABBV Stock Price Target | AbbVie Analyst Ratings

1 week from now

Sep 29, 2020 · This price target is based on 20 analysts offering 12 month price targets for AbbVie in the last 3 months. The average price target is $203.83, with a high forecast of …

pricetargets.com

$221
OFF

ABBV Stock Quote Price And Forecast | CNN

1 week from now

Latest ABBV news. Nov 06 7:37am ET AbbVie price target raised to $221 from $212 at Guggenheim by TipRanks Nov 06 7:33am ET Truist Financial Sticks to Its Buy Rating for …

cnn.com

$189
OFF

Analyst Scoreboard: 6 Ratings For AbbVie | Markets Insider

1 week from now

Jun 5, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $189.5, along with a high estimate of $200.00 and a low …

businessinsider.com

$137.05
OFF

AbbVie Inc (ABBV) Stock Price & News - Google Finance

1 week from now

Some Investors May Be Willing To Look Past AbbVie's (NYSE:ABBV) Soft Earnings. 3 days ago. Benzinga. ... The range between the high and low prices over the past 52 weeks. $137.05 - …

google.com

11%
OFF

AbbVie Stock Falls 11% In A Month: Should You Buy The Dip?

1 week from now

2 days ago · AbbVie’s ABBV stock declined almost 11% in the past month, mainly due to a recent pipeline setback.In November, AbbVie announced that two registration-enabling phase II …

yahoo.com

$171.74
OFF

AbbVie (NYSE:ABBV) Stock Quotes, Forecast And News Summary

1 week from now

3 days ago · A. The stock price for AbbVie (NYSE: ABBV) is $171.74 last updated November 12, 2024 at 7:55 PM EST. Q.

benzinga.com

$3.00
OFF

AbbVie (ABBV) Stock Price, News & Analysis - MarketBeat

1 week from now

3 days ago · AbbVie Inc. (NYSE:ABBV) announced its earnings results on Wednesday, October, 30th. The company reported $3.00 EPS for the quarter, topping the consensus estimate of …

marketbeat.com

$215.00
OFF

Citigroup Lowers AbbVie (NYSE:ABBV) Price Target To $215.00

1 week from now

2 days ago · BMO Capital Markets lowered their price target on AbbVie from $228.00 to $208.00 and set an “outperform” rating on the stock in a research report on Tuesday.

etfdailynews.com

$0.63
OFF

JPMorgan Chase & Co. Cuts AbbVie (NYSE:ABBV) Price Target

1 week from now

4 days ago · Get Our Latest Stock Analysis on AbbVie. AbbVie Stock Performance. NYSE:ABBV traded down $0.63 during mid-day trading on Wednesday, reaching $170.46. 8,482,386 …

marketbeat.com

FAQs about AbbVie (NYSE:ABBV) Price Target Lowered to $215.00 at Citigroup Coupon?

Should you buy AbbVie (abbv)?

Out of the 18 analysts, 4 have given a hold rating, 13 have given a buy rating, and 1 has given a strong buy rating for ABBV. According to the 18 analysts' twelve-month price targets for AbbVie, the average price target is $198.47. The highest price target for ABBV is $225.00, while the lowest price target for ABBV is $150.00. ...

What is the price target for AbbVie (abbv)?

The highest price target for ABBV is $225.00, while the lowest price target for ABBV is $150.00. The average price target represents a forecasted upside of 5.08% from the current price of $188.87. Enter your email address to receive the latest news and analysts' ratings for AbbVie and its competitors. ...

Is AbbVie a good stock to buy?

AbbVie's strong portfolio of pharmaceutical products, including Humira, Skyrizi, Rinvoq, and Imbruvica, provides diversified revenue streams. Recent analyst ratings have been overwhelmingly positive, with multiple firms raising price targets and issuing buy ratings on AbbVie. ...

Which sell-side analysts are buying AbbVie (abbv) stock?

The following sell-side analysts have issued research reports on AbbVie in the last year: Argus, Barclays PLC, BMO Capital Markets, Cowen Inc, Daiwa Capital Markets, Mizuho, Morgan Stanley, Piper Sandler, Royal Bank of Canada, Societe Generale, SVB Leerink LLC, Truist, Truist Securities, Wells Fargo & Company, and Zacks Investment Research. ...

Is AbbVie a good company?

Stay up to date on AbbVie analyst ratings. AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. ...

Are Abbvie insiders buying or selling more stock?

In the past three months, AbbVie insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,403,580.00 in company stock. Only 0.25% of the stock of AbbVie is held by insiders. 70.23% of the stock of AbbVie is held by institutions. ...